SCHEMBL8618666

SCHEMBL8618666

COc1cc(OC)c2c(NC(=N)NC=O)cc(-c3ccccc3)nc2c1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.44
ALDH1A1 P00352 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
TACR3 P29371 3/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
NQO2 P16083 2/20 0.41
PLA2G2A P14555 1/20 0.40
HPGD P15428 4/20 0.40
LMNA P02545 3/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 2/20 0.40
ABCB1 P08183 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
HTT P42858 1/20 0.40
ACP1 P24666 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8620632 0.88 HPGD (0.44) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL8620380 0.87 CA2 (0.39) KDM4EALDH1A1SMN1; SMN2TACR3MEN1
SCHEMBL8619826 0.86 ALDH1A1 (0.44) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL8616302 0.84 PDE10A (0.43) KDM4EALDH1A1SMN1; SMN2TACR3MEN1
SCHEMBL8617947 0.84 MEN1 (0.43) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL8616497 0.83 TACR3 (0.61) KDM4EALDH1A1SMN1; SMN2TACR3MEN1
SCHEMBL8620945 0.82 NQO2 (0.56) KDM4EALDH1A1SMN1; SMN2TACR3MEN1
SCHEMBL8620866 0.82 ALDH1A1 (0.46) KDM4EALDH1A1SMN1; SMN2TACR3MEN1
SCHEMBL8614352 0.82 PDE10A (0.43) KDM4EALDH1A1SMN1; SMN2TACR3MEN1
SCHEMBL8614038 0.82 PDE10A (0.39) KDM4EALDH1A1SMN1; SMN2TACR3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed